Company Profile

Macrocure Ltd. is a clinical-stage biopharmaceutical company focused on developing a novel therapeutic platform to address chronic and hard-to-heal wounds, such as diabetic foot ulcers (DFUs) and venous leg ulcers (VLUs).

Read More

NASDAQ: MCUR

$ 1.51
0.00 (0.00%)
Day High: N/A
Day Low:  N/A
Volume:    N/A
4:00 PM ET on Jan 20, 2017

Delayed at least 20 minutes.